[Download Full Document (PDF)]
Deep Dive | Your Zip Code is an Immune Organ
Debate | Redefining Immune Disease as Ecological Failure
Critique | Grounding immune coherence in clinical practice
Explainer | Ecology of Immune Disease
Cinematic | The Architecture of Immune Coherence
Click on infographic to enlarge
Executive Summary
Human immune pathology is often described as either insufficient immunity or excessive immunity. This distinction remains clinically useful. Immunodeficiency, impaired vaccine response, severe infection, immunosenescence, and cancer immune escape involve failures of protection. Sepsis, allergy, autoimmunity, autoinflammation, fibrosis, atherosclerosis, chronic inflammatory disease, and some forms of tissue remodeling involve excessive, misdirected, persistent, or poorly resolved immune activity.
Yet the “too much / too little” model is no longer sufficient. Immune disease often arises not merely because immunity is weak or strong, but because immune activity loses proportion, context, timing, memory discipline, resolution, and repair. The same immune pathway may be protective in one setting and pathogenic in another. The same inflammatory memory may protect against infection but worsen chronic disease. The same tissue repair programme may restore function or produce fibrosis. The same antigen may be tolerated, ignored, attacked, remembered, or repaired around depending on the tissue ecology in which it appears.
This white paper therefore proposes a more generative frame: immune coherence.
A healthy immune system must perform five interlocking operations:
- Sense danger without hallucinating danger.
- Respond without destroying the tissue it protects.
- Tolerate what is life-compatible.
- Remember what is worth remembering.
- Resolve and repair without scarring the future.
Key Translation. Minimum-Sufficient, Condition-Restoring Care |
|
These five imperatives imply a corresponding ethic of care: intervention should be sufficient to prevent avoidable harm, but not so excessive that it disrupts the conditions required for tolerance, resolution, and repair. In biomedical terms, this means minimum-sufficient, condition-restoring care: reducing unnecessary danger, preserving protective memory, restoring barriers and microbial ecologies, supporting active resolution, repairing tissue function, and escalating decisively when self-regulation fails. In this white paper, this ethic is later named wu-wei prevention — not passivity, but disciplined action that restores the conditions under which immune systems can recover coherence. The corresponding clinical and public-health question is therefore not only “Which pathway should be blocked or stimulated?” but “What is the least forceful and most condition-restoring action sufficient to preserve life, prevent irreversible harm, and enable immune coherence to return?” |
Immune pathology occurs when one or more of these operations fail. False danger sensing contributes to allergy, autoinflammation, and some autoimmune states. Missed danger contributes to infection, cancer escape, and poor surveillance. Disproportionate response contributes to sepsis, cytokine injury, severe viral immunopathology, and tissue damage. Impaired tolerance contributes to autoimmunity, food allergy, asthma, eczema, and inflammatory bowel disease. Maladaptive memory and trained inflammatory readiness contribute to chronic inflammatory multimorbidity. Failed resolution and maladaptive repair contribute to atherosclerosis, fibrosis, chronic wounds, chronic pain, organ dysfunction, and scarring.
The framework begins by affirming mainstream immunology. Adaptive immune memory is crucial for survival. Memory T cells, memory B cells, long-lived plasma cells, and antibodies enable rapid and effective pathogen clearance after re-exposure, minimizing damage to the host. The ability of T and B cells to form memory after antigen exposure is the rationale behind vaccination.
The paper is therefore not anti-vaccine, anti-immunology, anti-biologic therapy, anti-antibiotic, anti-immunosuppression, or anti-immunotherapy. The argument is not that defense is unreal. Defense is real and indispensable. The argument is that defense is one outcome of a broader immune ecology. The immune system also maintains tissue homeostasis, interprets danger, negotiates microbial coexistence, forms adaptive and innate memory, coordinates repair, and actively resolves inflammation.
Danger theory provides the first major bridge from classical immunology to immune coherence. Immune responses are not dictated by antigen alone. Immunogenicity depends on the combination of antigenicity — the ability to be recognized by T cell receptors or antibodies — and adjuvanticity — additional signals arising from tissue damage, stress, infection, or microbial context. This means that immune meaning is not located in antigen alone. It emerges from the relation among antigen, tissue state, microbial signals, stress physiology, and prior immune history.
Trained immunity provides the second bridge. Innate immune cells and haematopoietic stem and progenitor cells can undergo epigenetic and metabolic reprogramming after infectious or inflammatory encounters. These changes can produce beneficial readiness in infection and cancer, or maladaptive inflammatory amplification in chronic disease, depending on context. This gives biological depth to the idea that social and ecological histories can become immune histories.
Resolution biology provides the third bridge. Inflammation does not simply fade away. Its termination is an active, coordinated programme that controls inflammatory magnitude and duration, promotes repair, and limits pain. Specialized pro-resolving mediators — including lipoxins, resolvins, protectins, and maresins — help coordinate this process. The successful endpoint of inflammation is therefore not mere suppression, but restored tissue function.
Vaz et al.’s immunological drift framework provides a deeper historical-systemic bridge. Drawing on Maturana and Mpodozis, it challenges the reduction of lymphocyte organization to an optimized defense apparatus alone, while preserving immune activity as a historically generated organization whose protective effects are real but not exhaustive of its biological meaning.
At the population level, the central question becomes:
What upstream conditions are chronically generating danger, training inflammatory memory, damaging barriers, impairing tolerance, exhausting defense, and preventing resolution?
This question points to a wider prevention agenda: maternal-child health, nutrition, microbiome-preserving practices, clean air, reduced toxic exposures, sleep, infection control, vaccination equity, oral health, metabolic health, healthier food systems, stress-buffering environments, housing, occupational protections, antimicrobial stewardship, climate resilience, and early treatment of chronic inflammation before marrow and tissue ecologies become trained into disease.
The paper’s practical ethic is wu-wei prevention: not therapeutic passivity, but minimum-sufficient, context-sensitive, condition-restoring action. In immune health, wu-wei means acting with the grain of immune biology: reducing unnecessary danger, preserving protective memory, restoring barriers and microbial ecology, preventing maladaptive inflammatory training, supporting endogenous resolution and repair, and reserving targeted force for states of acute danger, irreversible damage, or failed self-regulation.
This approach does not oppose targeted therapy. In established immune-mediated disease, targeted blockade may be the most coherent action available because it prevents irreversible tissue loss, buys time for repair, reduces inflammatory burden, and restores life-capacity. In severe infection, antimicrobials may be necessary to remove danger before inflammation becomes destructive. In anaphylaxis, epinephrine is the minimum sufficient action because delay can be fatal. In cancer, immunotherapy, surgery, chemotherapy, or radiotherapy may be necessary to restore surveillance and prevent malignant progression.
The critique is not of targeted therapy itself. The critique is of relying on downstream rescue while neglecting the upstream and tissue-level conditions that sustain recurrence, non-resolution, and maladaptive repair.
The prevention of immune disease cannot be reduced to suppressing inflammatory pathways after pathology has become established. Nor can it be reduced to strengthening immunity in a general sense. The task is more precise: to create the biological, social, and planetary conditions under which immune systems can sense danger without hallucinating danger, respond without excessive collateral damage, tolerate what is life-compatible, remember what is worth remembering, and resolve and repair without scarring the future.
In this sense, immune health is not only a property of individuals. It is an achievement of social ecology.
And more deeply, it is an achievement of civilizational learning: a movement from control to coherence, from rescue to prevention, from suppression to resolution, from extraction to regeneration, and from fragmented knowledge to a shared capacity to care.
Domains and Operations of the Immune Coherence Framework
Please scroll to the right to see the right columns| Immune Operation | Biological Grounding | Failure Mode | Disease Examples | Population-Health Implication | Policy Lever |
|---|---|---|---|---|---|
| Sensing | DAMPs, MAMPs, PRRs, inflammasomes, epithelial alarmins, tissue stress | Missed danger or false danger (hallucinating danger) | Allergy, autoinflammation, infection, cancer escape | Reduce pollution, toxic exposure, chronic infection, and metabolic stress | Clean-air standards, housing remediation, workplace protections, and wildfire-smoke preparedness |
| Context interpretation | Antigenicity plus adjuvanticity; local tissue state; stress and damage signals | Misclassification of exposure; harmful response to compatible signals | Asthma, eczema, allergic rhinitis, food allergy, and IBD | Protect tissue integrity, reduce chronic injury, and improve early care | Early barrier care, housing remediation, and pollution reduction |
| Tolerance | Central and peripheral tolerance, mucosal tolerance, Tregs, and checkpoints | Autoimmunity, allergy, IBD, and food intolerance | Lupus, rheumatoid arthritis, type 1 diabetes, and coeliac disease | Protect microbiome, barriers, early-life ecology, clean air, and healthy diet | Maternal-child care, antibiotic stewardship, breastfeeding support, and food policy |
| Response | Innate and adaptive effector pathways, cytokines, antibodies, complement, and phagocytosis | Sepsis, cytokine injury, and collateral tissue damage (disproportionate response) | Sepsis, ARDS, cytokine storm, and severe viral immunopathology | Early treatment, emergency care, and chronic disease prevention | Early-warning systems, primary care access, and emergency preparedness |
| Memory / Training | T cells, B cells, plasma cells, antibodies, vaccination; Epigenetic/metabolic innate memory, and HSPCs | Poor protection, weak vaccine response, or maladaptive inflammatory training | Immunodeficiency and chronic inflammatory multimorbidity (e.g., Periodontitis, RA, CVD) | Vaccination equity, maternal-child health, and prevention of obesity, diabetes, and stress | Immunization systems, food security, metabolic prevention, and dental-care access |
| Resolution | Specialized pro-resolving mediators (SPMs), efferocytosis, lipid class switching, and macrophage transitions | Chronic inflammation, non-resolution, and persistent pain | Atherosclerosis, chronic wounds, chronic pain, and vascular disease | Support nutrition, sleep, recovery, and metabolic health | Sleep policy, nutrition access, rehabilitation, and pro-resolving research |
| Repair | Stroma, fibroblasts, matrix, endothelium, and regeneration | Fibrosis, scarring, remodeling, and organ dysfunction | Airway remodeling, CKD, organ fibrosis, and scarring | Reduce repeated injury; enable rehabilitation and recovery | Workplace safety, early treatment, anti-fibrotic research, and chronic pain care |
